STROMUSC Finasteride 5mg*100/bottle Oral Tablets

STROMUSC Finasteride 5mg*100/bottle Oral Tablets
Product Introduction:
Finasteride is a 5α-reductase inhibitor that effectively slows the progression of androgenic alopecia and reduces the size of prostate enlargement by blocking the conversion of testosterone to dihydrotestosterone (DHT). It is used in the medical treatment of male pattern baldness and benign prostatic hyperplasia (BPH), significantly improving hair density and urinary function, with a low dose (1 mg/day) maintaining efficacy.
Send Inquiry
Description
Technical Parameters

Finasteride 5mg 100 tablets/bottle Core Description *

Pharmaceutical -Grade Preparations | 5α-Reductase Inhibitor

Chemical name : N-(1,1-dimethylethyl)-3-oxo-4-aza-5α-androst-1-ene-17β-amide

CAS number : 98319-26-7

Molecular formula : C₂₃H₃₆N₂O₂

Molecular weight : 372.55

Specifications : 5mg/tablet, 100 tablets/bottle

Dosage form : Film-coated tablets

Appearance : Light blue or white tablets with a dividing line


Core Effects

Finasteride is a specific 5α-reductase inhibitor . Due to its high efficacy in inhibiting dihydrotestosterone (DHT) production , it is widely used in the treatment of male androgenic alopecia and the management of benign prostatic hyperplasia .

✅ ​Precisely inhibit DHT conversion :

Inhibits type II 5α-reductase , reducing serum DHT levels by more than 70%

Reduce DHT attack on hair follicles and delay hair loss from the root

✅ ​Prostate protection effect :

Reduce prostate size and improve symptoms of benign prostatic hyperplasia

Reduce the risk of acute urinary retention and the need for surgery

✅ High security features :

Does not affect testosterone levels and maintains normal sexual function

Selective inhibition with lower risk of side effects

✅ Advantages :

Take orally once a day , high medication compliance

Long-term effects are stable and significant with continued use


End Product Preparation Guide

1. Tablet preparation (5 mg/tablet) :

Example recipe (for 1000 tablets):

Finasteride raw material: 5.0g

Microcrystalline cellulose: 80.0g

Lactose: 50.0g

Cross-linked carboxymethyl cellulose sodium: 8.0g

Magnesium stearate: 2.0g

Preparation process :

Raw material pretreatment : micronization (D90≤10μm)

Equal amount incremental mixing : gradually mix with diluent

Wet granulation : granulate with appropriate amount of purified water and dry in fluid bed at 50°C

Granulation : 20 mesh sieve granules, add flow aids and lubricants

Tableting : 8mm round die, 8-10kN pressure tableting

Film coating : Gastro-soluble film coating to improve stability and palatability

Quality Control :

Content uniformity : RSD≤3% (UV-HPLC detection)

Dissolution rate : ≥85% in 30 minutes (paddle method, 50 rpm)

Related substances : Single impurity ≤ 0.5%, total impurities ≤ 1.0%

2. Preparation Notes :

Anti- cross contamination : Dedicated production line to avoid cross contamination with other drugs

Female operation protection : Pregnant women are prohibited from using this product, and strict protection is required during the production process

Packaging requirements : Aluminum foil blister packaging, moisture-proof and light-proof


Usage Protocol

1. Male hair loss treatment :

Standard dose : 1 mg/day (1 tablet divided into 5 portions)

Taking time : fixed time every day, before or after meals

Time to see results :

3-6 months: Hair loss decreases

6-12 months: New hair is obvious

Long-term use: The effect is maintained continuously

2. Treatment of benign prostatic hyperplasia (BPH) :

Therapeutic dose : 5 mg/day (1 tablet/day)

Symptom improvement :

3-6 months: Improved urine flow rate

6-12 months: Prostate volume shrinks

Maintenance therapy : Long-term use to prevent progression

3. Dose fractionation method :

Precise splitting : Use a tablet splitter to split the pills evenly

Storage method : After splitting, keep the tablets sealed and away from light.

Dose adjustment : Individualized adjustment based on efficacy and tolerability

4. Use in special populations :

Elderly : No dosage adjustment is required; monitor PSA carefully.

Hepatic and renal insufficiency : Mild to moderate, no adjustment required; use with caution in severe cases

Women : Contraindicated for pregnant women and women of childbearing age


Why choose finasteride ?

Precise targeted treatment to inhibit DHT production from the root

Dual treatment advantages , suitable for both hair loss and benign prostatic hyperplasia

Excellent long-term safety , 20 years of clinical experience


Quality Assurance :

GMP compliant production , content uniformity testing for each batch

Stability test : Accelerated test for 6 months meets the standard

Third-party laboratory report (COA) is included with the product

Professional Packaging :

Moisture-proof bottle : 100 tablets/bottle, built-in desiccant

Light- proof : Brown glass bottle or aluminum-plastic blister

Child safety cap : prevent children from accidentally swallowing


Conclusion

Finasteride tablets are a standard treatment option for male androgenic alopecia and benign prostatic hyperplasia (BPH) . They are particularly suitable for early intervention of hair loss and management of prostate symptoms . The recommended dose is 1mg/day (for hair loss) or 5mg/day (for BPH) .

Need anything, please contact us

WhatsApp

+852 4671 8216

Telegram

Allenraws

Email

Allenraws810@gmail.com

product-1268-769

 

Hot Tags: stromusc finasteride 5mg*100/bottle oral tablets, China stromusc finasteride 5mg*100/bottle oral tablets manufacturers, suppliers, factory, Steroid Cycle Support, Methyltestosterone to use, Increases phosphocreatine stores, dromostanolone propionate, Letrozole Elevates Natural Testosterone By 30 50 , steroid finished tablets

Send Inquiry
contact us